Allegiant Travel (NASDAQ: ALGT) director receives 1,000-share restricted stock grant

Rhea-AI Filing Summary

Kennedy Thomas C reported acquisition or exercise transactions in this Form 4 filing.

Allegiant Travel Co director Thomas C. Kennedy received a grant of 1,000 shares of common stock as restricted stock. The award was made at no cash purchase price and will vest on May 13, 2027. After this grant, he directly holds 6,894 Allegiant Travel Co shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kennedy Thomas C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,000	$0.00	--

Holdings After Transaction: Common Stock — 6,894 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 1,000 shares Post-transaction holdings: 6,894 shares Grant vesting date: May 13, 2027 +1 more

4 metrics

Restricted stock grant 1,000 shares Common Stock award to director Thomas C. Kennedy

Post-transaction holdings 6,894 shares Directly held common shares after the grant

Grant vesting date May 13, 2027 Vesting of restricted stock grant

Transaction code A Grant, award, or other acquisition

Key Terms

restricted stock, transaction code A, Form 4, non-derivative

4 terms

restricted stock financial

"Grant of restricted stock with vesting on May 13, 2027"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

transaction code A financial

"transaction_code_description": "Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

"transaction_type": "non-derivative"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kennedy Thomas C

(Last) (First) (Middle)

1201 N TOWN CENTER DR

(Street)

LAS VEGAS NEVADA 89144

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Allegiant Travel CO [ ALGT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		1,000	A	$0(1)	6,894	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock with vesting on May 13, 2027

	Robert B. Goldberg, under power of attorney	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Allegiant Travel Co (ALGT) report for Thomas C. Kennedy?

Allegiant Travel Co reported that director Thomas C. Kennedy received a grant of 1,000 shares of common stock as restricted stock. This was classified as a grant or award acquisition, increasing his directly held position to 6,894 shares after the transaction.

Was the Allegiant Travel Co (ALGT) Form 4 transaction a purchase or a grant?

The Form 4 shows a grant, not an open market purchase. Thomas C. Kennedy acquired 1,000 Allegiant Travel Co common shares through a restricted stock award, recorded with transaction code A for grant, award, or other acquisition, at a stated price of zero per share.

When do Thomas C. Kennedy’s newly granted Allegiant Travel Co (ALGT) shares vest?

The 1,000-share restricted stock grant to Thomas C. Kennedy vests on May 13, 2027. Until that vesting date, the shares are subject to the restricted stock terms disclosed, which typically include continued service or other specified vesting conditions.

How many Allegiant Travel Co (ALGT) shares does Thomas C. Kennedy hold after this Form 4 transaction?

After receiving the 1,000-share restricted stock grant, Thomas C. Kennedy directly holds 6,894 Allegiant Travel Co common shares. This figure reflects his position immediately following the reported grant, as disclosed in the post-transaction ownership column.

Does the Allegiant Travel Co (ALGT) Form 4 show any insider sales by Thomas C. Kennedy?

No insider sales are reported in this Form 4. The filing shows only an acquisition via a restricted stock grant of 1,000 shares, with no sell transactions, tax-withholding dispositions, gifts, or derivative exercises disclosed for the reported date.